Share Share Share

Aberrant PDGFR Signaling as a Target for Treatment of the Infantile Myofibromatosis with Sunitinib

PEDIATRIC BLOOD & CANCER

Veselska, R; Sramek, M; Neradil, J; Macigova, P; Mudry, P; Melicharkova, K; Slaby, O; Vanackova, J; Sterba, J, 2017: Aberrant PDGFR Signaling as a Target for Treatment of the Infantile Myofibromatosis with Sunitinib. PEDIATRIC BLOOD & CANCER 64, p. S296 - S296

Research Groups:

• Molecular Oncology - Solid Cancer

CEITEC authors:

• Prof. Ondřej Slabý, Ph.D.
• Jitka Vaňáčková, Ph.D.